Lux Capital — 2015 Investments
5 investments dated 2015 · listed companies and verified rows first · show all
Danvers, US
Helen Greiner(Executive Officer, Director, Promoter)
BoardAnita Jones(Director)Tad Elmer(Director)
Board seatBilal Zuberi· per SEC Form D
Co-investorsPerot JainBessemer Venture PartnersGeneral Catalyst
Kyruus Health provides a healthcare access platform that unifies provider and member data to help patients find, schedule, and access care.
Digital HealthHealthtechSaaSBoston, US
Graham Gardner, MD, MBA(Founder)inDonald Trigg(Director)Graham Gardner(Executive Officer, Director)Robert Paull(Director)Robert Higgins(Director)Edward Park(Director)
Board seatRobert Paull· per SEC Form D · $37M raise · filed Sep 2015
Co-investorsFrancisco PartnersTRANSFORMATION CAPITALVenrockHighland Capital PartnersNew Leaf Venture PartnersVenrock Associates
CleantechIrvine, US
John M. Raymont, Jr.(Executive Officer, Director)William Gallo(Executive Officer, Director)Stephen Wright(Executive Officer)Stephen Piccolo(Director)Teresa Saucedo-Artino(Executive Officer)Michael Steuert(Director)
Matterport provides 3D imaging and digital twin technology for real estate, construction, facilities management, and property marketing, enabling clients to visualize spaces remotely and make data-driven decisions.
Construction TechConsumerEnterprise SoftwarePropTechSunnyvale, US
Matt Bell(Founder)David Gausebeck(Founder/CTO)inRJ Pittman(CEO)inWillian Brown(Chief Executive Officer)Michael Beebe(Chief Operating Officer)Sundeep Peechu(Director)
Co-investorsBrighter CapitalCapria VenturesDCM VenturesFelicis VenturesGoresiGlobe Partners+16 more
San Francisco catalyst company that converted natural gas to ethylene and fuels; acquired by McDermott in 2019.
San Francisco, US
Edward J Dineen(Executive Officer, Director)Jeffrey P. Wood(Executive Officer)
BoardClinton Bybee(Director)inMichel Maloof(Director)Leighton Read(Director)Paula Reynolds(Director)
Co-investorsARCH Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.